Apoptotic cell death in disease—Current understanding of the NCCD 2023

I Vitale, F Pietrocola, E Guilbaud… - Cell Death & …, 2023 - nature.com
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase
family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis …

Hallmarks of brain aging: adaptive and pathological modification by metabolic states

MP Mattson, TV Arumugam - Cell metabolism, 2018 - cell.com
During aging, the cellular milieu of the brain exhibits tell-tale signs of compromised
bioenergetics, impaired adaptive neuroplasticity and resilience, aberrant neuronal network …

Microglia in Alzheimer's disease

H Sarlus, MT Heneka - The Journal of clinical investigation, 2017 - Am Soc Clin Investig
Microglia are brain-resident myeloid cells that mediate key functions to support the CNS.
Microglia express a wide range of receptors that act as molecular sensors, which recognize …

[HTML][HTML] Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease

WY Wang, MS Tan, JT Yu, L Tan - Annals of translational medicine, 2015 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …

[HTML][HTML] TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants–past, present and future

LM Sedger, MF McDermott - Cytokine & growth factor reviews, 2014 - Elsevier
Abstract Tumor Necrosis Factor (TNF), initially known for its tumor cytotoxicity, is a potent
mediator of inflammation, as well as many normal physiological functions in homeostasis …

Glial contributions to neurodegeneration in tauopathies

CEG Leyns, DM Holtzman - Molecular neurodegeneration, 2017 - Springer
Tauopathies are a broad set of neurodegenerative dementias characterized by aggregation
of the tau protein into filamentous inclusions that can be found in neurons and glial cells …

Targeting tumor necrosis factor alpha for Alzheimer's disease

B Decourt, DK Lahiri… - Current Alzheimer …, 2017 - ingentaconnect.com
Alzheimer's disease (AD) affects an estimated 44 million individuals worldwide, yet no
therapeutic intervention is available to stop the progression of the dementia …

Molecular and cellular pathways contributing to brain aging

A Zia, AM Pourbagher-Shahri, T Farkhondeh… - Behavioral and Brain …, 2021 - Springer
Aging is the leading risk factor for several age-associated diseases such as
neurodegenerative diseases. Understanding the biology of aging mechanisms is essential …

Inflammatory process in Alzheimer's Disease

MA Meraz-Ríos, D Toral-Rios… - Frontiers in integrative …, 2013 - frontiersin.org
Alzheimer Disease (AD) is a neurodegenerative disorder and the most common form of
dementia. Histopathologically is characterized by the presence of two major hallmarks, the …

Tumor necrosis factor α inhibition for Alzheimer's disease

R Chang, KL Yee, RK Sumbria - Journal of central nervous …, 2017 - journals.sagepub.com
Tumor necrosis factor α (TNF-α) plays a central role in the pathophysiology of Alzheimer's
disease (AD). Food and Drug Administration–approved biologic TNF-α inhibitors are thus a …